Supplies - 231901-2021

07/05/2021    S89

Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States

2021/S 089-231901

Contract award notice

Results of the procurement procedure

Supplies

Legal Basis:
Regulation (EU, Euratom) No 2018/1046

Section I: Contracting authority

I.1)Name and addresses
Official name: European Commission
Postal address: B232 5/P047
Town: Brussels
NUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-Hoofdstad
Postal code: B-1049
Country: Belgium
E-mail: sante-procurement@ec.europa.eu
Internet address(es):
Main address: http://ec.europa.eu/dgs/health_food-safety/index_en.htm
I.4)Type of the contracting authority
European institution/agency or international organisation
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Production, priority-purchasing options and supply of COVID-19 Vaccines, including adapted vaccines to SARS-CoV2 variants and paediatric formulations of such vaccines for EU Member States

II.1.2)Main CPV code
33651600 Vaccines
II.1.3)Type of contract
Supplies
II.1.4)Short description:

The subject of this tender is the production, priority-purchasing options and supply of mRNA based COVID-19 Vaccines, developed and produced by BioNTech-Pfizer-, for the participating Member States, and adapted vaccines for SARS-CoV2 variants and pediatric formulations of such vaccines.

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 1.00 EUR
II.2)Description
II.2.2)Additional CPV code(s)
33651600 Vaccines
II.2.3)Place of performance
NUTS code: BE1 Région de Bruxelles-Capitale / Brussels Hoofdstedelijk Gewest
II.2.4)Description of the procurement:

Please see Point II.1.4 of the present notice.

II.2.5)Award criteria
Quality criterion - Name: In accordance with the invitation to negotiate / Weighting: 90
Price - Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

The maximum value of the contract, provided in point II.1.7, will not be mentioned in the contract award notice due to article 163.3 of the Financial Regulation. The value stated in sections II.1.7 and V.2.4 should therefore be disregarded.

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons
  • Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the directive
Explanation:

It currently appears that BioNTech / Pfizer is the only candidate that can reliably deliver a very large number of doses produced within the EU of an efficient, safe and adaptable vaccine conferring immunity to SARS-CoV2.

In addition, the Commission needs to secure the purchase of the vaccine in advance in order to receive a timely delivery, essential for the organisation of the large-scale vaccination campaign.

IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice

Section V: Award of contract

A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:
07/05/2021
V.2.2)Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: yes
V.2.3)Name and address of the contractor
Official name: Pfizer Inc.
Town: New York
NUTS code: US United States
Country: United States
The contractor is an SME: no
V.2.3)Name and address of the contractor
Official name: BioNTech Manufacturing GmbH
Town: Mainz
NUTS code: DE Deutschland
Country: Germany
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 1.00 EUR
V.2.5)Information about subcontracting
The contract is likely to be subcontracted

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: General Court
Postal address: rue du Fort Niedergrünewald
Town: Luxembourg
Postal code: 2925
Country: Luxembourg
E-mail: generalcourt.registry@curia.europa.eu
Telephone: +352 4303-1
Fax: +352 4303-2100
Internet address: http://curia.europa.eu
VI.5)Date of dispatch of this notice:
07/05/2021